Clinical Trial Update: Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Subjects With Moderate to Severe Essential Hypertension [Phase 3]

View source ↗

Summary

Open-label Phase 3 study evaluating the long-term safety and efficacy of a fixed-dose combination of Nifedipine GITS and Candesartan Cilexetil in adults with es…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Nifedipine Gastrointestinal Therapeutic System (nifedipine)
• candesartan cilexetil (candesartan cilexetil)

Snippet

Sponsor: Bayer | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2015-08-17